Lipoprotein(a) Is the Best Single Marker in Assessing Unstable Angina Pectoris

Table 1

Demographic characteristics and blood lipid and inflammatory markers in patients with ischemic heart disease.

	SAP	USAP	STEMI	Controls
Male/female (N)	52/30	50/30	72/34	30/19
Age years	61.3±6.5	60.8±9.8	60.2±12.7	59.1±9.7
Troponin I, ng/mL	0.0 (0.0–1.68)	0.03 (0.0-3.7)^∗	12.8 (0.0-159.6)^∗∗∗	0.0 (0.0–0.01)
TG, mmol/L	1.88 (0.58-21.4)^∗	2.08 (0.56-7.6)^∗∗∗	1.90 (0.56-4.9)^∗	1.30 (0.46–4.18)
Tc, mmol/L	5.60±1.20	5.78±1.72	5.91±1.57	5.48±0.49
HDL-c, mmol/L	1.16±0.28	1.00±0.31^∗∗∗	1.06±0.26^∗∗∗	1.15±0.28
LDL-c, mmol/L	3.47±1.05	3.55±1.40	3.88±1.28	3.51±0.59
Lp(a), mg/dL	14.4 (3.6-67.8)^∗∗∗	22.7 (5.9-88.9)^∗∗∗	17.8 (4.8-79.0)^∗∗∗	5.6 (2.9–19.7)
ApoA-I, g/L	1.13±0.30^∗∗∗	1.04±0.29^∗∗∗	1.11±0.17^∗∗∗	1.34±0.21
ApoB, g/L	1.06±0.38	1.17±0.40	1.25±0.31	1.17±0.14
oxLDL, ng/mL	211 (11.7–1925)	143 (7-1550)^∗	140 (15–2105)	195 (18–705)
hsCRP, g/L	3.0(0.4-84.35)^∗	5.8(0.43-178.3)^∗∗,b	18.0 (0.56-270)^∗∗∗,c	1.5 (0.1–16.5)
Fibrinogen, g/L	4.29±1.22	5.03±1.49^∗∗	5.06±2.46^∗	3.92±1.03
Neopterin, nmol/L	14.9(3-57)^∗∗∗	14.3(1-105)^∗∗,a	13.0 (1–52)	13.4 (1–19.6)
iNOS, U/mL	2.2 (0.5–4.7)	2.9 (0.9–6.0)	3.0 (0.9–6.2)	2.2 (0.6–9.3)
NO2/NO3,𝜇mol/L	96 (35–197)	125(52-199)^∗∗,b	102 (61–243)	97 (57–230)
TNF-α, pg/mL	12.74±1.25	13.78±1.93	14.47±2.15	13.60±2.19

The results are presented as means±SD for parametric, and median (min–max) for nonparametric values ^∗𝑃<.05 versus controls, ^∗∗𝑃<.01 versus controls, ^∗∗∗𝑃<.001 versus controls, ^a𝑃<.05 versus STEMI, ^b𝑃<.01 versus SAP, ^c𝑃<.001 versus SAP.